GP Vaccination Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of GP Vaccination in global, including the following market information:
Global GP Vaccination Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global GP Vaccination Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five GP Vaccination companies in 2021 (%)
The global GP Vaccination market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GP Vaccination include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson?Johnson, Heat Biologics and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GP Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GP Vaccination Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GP Vaccination Market Segment Percentages, by Type, 2021 (%)
Global GP Vaccination Market Segment Percentages, by Application, 2021 (%)
Global GP Vaccination Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies GP Vaccination revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies GP Vaccination revenues share in global market, 2021 (%)
Key companies GP Vaccination sales in global market, 2017-2022 (Estimated), (K Units)
Key companies GP Vaccination sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global GP Vaccination Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global GP Vaccination Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five GP Vaccination companies in 2021 (%)
The global GP Vaccination market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GP Vaccination include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson?Johnson, Heat Biologics and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GP Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GP Vaccination Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GP Vaccination Market Segment Percentages, by Type, 2021 (%)
- DNA
- Non-replicating Viral Vector
- Protein Subunit
- RNA
- Others
Global GP Vaccination Market Segment Percentages, by Application, 2021 (%)
- Adults
- Children
Global GP Vaccination Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies GP Vaccination revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies GP Vaccination revenues share in global market, 2021 (%)
Key companies GP Vaccination sales in global market, 2017-2022 (Estimated), (K Units)
Key companies GP Vaccination sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Moderna
- CanSino Biologicals
- Inovio Pharmaceuticals
- Shenzhen Geno-Immune Medical Institute
- GlaxoSmithKine
- Pfizer
- Johnson?Johnson
- Heat Biologics
- Sanofi
- Takis Biotech
- Zydus Cadila
- Codagenix
- GeoVax
- Bravovax
- Altimmune
- Vaxart
- Clover Biopharmaceuticals
- ImmunoPrecise
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 GP Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GP Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GP VACCINATION OVERALL MARKET SIZE
2.1 Global GP Vaccination Market Size: 2021 VS 2028
2.2 Global GP Vaccination Revenue, Prospects & Forecasts: 2017-2028
2.3 Global GP Vaccination Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top GP Vaccination Players in Global Market
3.2 Top Global GP Vaccination Companies Ranked by Revenue
3.3 Global GP Vaccination Revenue by Companies
3.4 Global GP Vaccination Sales by Companies
3.5 Global GP Vaccination Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 GP Vaccination Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers GP Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 GP Vaccination Players in Global Market
3.8.1 List of Global Tier 1 GP Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 GP Vaccination Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global GP Vaccination Market Size Markets, 2021 & 2028
4.1.2 DNA
4.1.3 Non-replicating Viral Vector
4.1.4 Protein Subunit
4.1.5 RNA
4.1.6 Others
4.2 By Type - Global GP Vaccination Revenue & Forecasts
4.2.1 By Type - Global GP Vaccination Revenue, 2017-2022
4.2.2 By Type - Global GP Vaccination Revenue, 2023-2028
4.2.3 By Type - Global GP Vaccination Revenue Market Share, 2017-2028
4.3 By Type - Global GP Vaccination Sales & Forecasts
4.3.1 By Type - Global GP Vaccination Sales, 2017-2022
4.3.2 By Type - Global GP Vaccination Sales, 2023-2028
4.3.3 By Type - Global GP Vaccination Sales Market Share, 2017-2028
4.4 By Type - Global GP Vaccination Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global GP Vaccination Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global GP Vaccination Revenue & Forecasts
5.2.1 By Application - Global GP Vaccination Revenue, 2017-2022
5.2.2 By Application - Global GP Vaccination Revenue, 2023-2028
5.2.3 By Application - Global GP Vaccination Revenue Market Share, 2017-2028
5.3 By Application - Global GP Vaccination Sales & Forecasts
5.3.1 By Application - Global GP Vaccination Sales, 2017-2022
5.3.2 By Application - Global GP Vaccination Sales, 2023-2028
5.3.3 By Application - Global GP Vaccination Sales Market Share, 2017-2028
5.4 By Application - Global GP Vaccination Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global GP Vaccination Market Size, 2021 & 2028
6.2 By Region - Global GP Vaccination Revenue & Forecasts
6.2.1 By Region - Global GP Vaccination Revenue, 2017-2022
6.2.2 By Region - Global GP Vaccination Revenue, 2023-2028
6.2.3 By Region - Global GP Vaccination Revenue Market Share, 2017-2028
6.3 By Region - Global GP Vaccination Sales & Forecasts
6.3.1 By Region - Global GP Vaccination Sales, 2017-2022
6.3.2 By Region - Global GP Vaccination Sales, 2023-2028
6.3.3 By Region - Global GP Vaccination Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America GP Vaccination Revenue, 2017-2028
6.4.2 By Country - North America GP Vaccination Sales, 2017-2028
6.4.3 US GP Vaccination Market Size, 2017-2028
6.4.4 Canada GP Vaccination Market Size, 2017-2028
6.4.5 Mexico GP Vaccination Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe GP Vaccination Revenue, 2017-2028
6.5.2 By Country - Europe GP Vaccination Sales, 2017-2028
6.5.3 Germany GP Vaccination Market Size, 2017-2028
6.5.4 France GP Vaccination Market Size, 2017-2028
6.5.5 U.K. GP Vaccination Market Size, 2017-2028
6.5.6 Italy GP Vaccination Market Size, 2017-2028
6.5.7 Russia GP Vaccination Market Size, 2017-2028
6.5.8 Nordic Countries GP Vaccination Market Size, 2017-2028
6.5.9 Benelux GP Vaccination Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia GP Vaccination Revenue, 2017-2028
6.6.2 By Region - Asia GP Vaccination Sales, 2017-2028
6.6.3 China GP Vaccination Market Size, 2017-2028
6.6.4 Japan GP Vaccination Market Size, 2017-2028
6.6.5 South Korea GP Vaccination Market Size, 2017-2028
6.6.6 Southeast Asia GP Vaccination Market Size, 2017-2028
6.6.7 India GP Vaccination Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America GP Vaccination Revenue, 2017-2028
6.7.2 By Country - South America GP Vaccination Sales, 2017-2028
6.7.3 Brazil GP Vaccination Market Size, 2017-2028
6.7.4 Argentina GP Vaccination Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa GP Vaccination Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa GP Vaccination Sales, 2017-2028
6.8.3 Turkey GP Vaccination Market Size, 2017-2028
6.8.4 Israel GP Vaccination Market Size, 2017-2028
6.8.5 Saudi Arabia GP Vaccination Market Size, 2017-2028
6.8.6 UAE GP Vaccination Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Moderna
7.1.1 Moderna Corporate Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna GP Vaccination Major Product Offerings
7.1.4 Moderna GP Vaccination Sales and Revenue in Global (2017-2022)
7.1.5 Moderna Key News
7.2 CanSino Biologicals
7.2.1 CanSino Biologicals Corporate Summary
7.2.2 CanSino Biologicals Business Overview
7.2.3 CanSino Biologicals GP Vaccination Major Product Offerings
7.2.4 CanSino Biologicals GP Vaccination Sales and Revenue in Global (2017-2022)
7.2.5 CanSino Biologicals Key News
7.3 Inovio Pharmaceuticals
7.3.1 Inovio Pharmaceuticals Corporate Summary
7.3.2 Inovio Pharmaceuticals Business Overview
7.3.3 Inovio Pharmaceuticals GP Vaccination Major Product Offerings
7.3.4 Inovio Pharmaceuticals GP Vaccination Sales and Revenue in Global (2017-2022)
7.3.5 Inovio Pharmaceuticals Key News
7.4 Shenzhen Geno-Immune Medical Institute
7.4.1 Shenzhen Geno-Immune Medical Institute Corporate Summary
7.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
7.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Major Product Offerings
7.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales and Revenue in Global (2017-2022)
7.4.5 Shenzhen Geno-Immune Medical Institute Key News
7.5 GlaxoSmithKine
7.5.1 GlaxoSmithKine Corporate Summary
7.5.2 GlaxoSmithKine Business Overview
7.5.3 GlaxoSmithKine GP Vaccination Major Product Offerings
7.5.4 GlaxoSmithKine GP Vaccination Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKine Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer GP Vaccination Major Product Offerings
7.6.4 Pfizer GP Vaccination Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Johnson?Johnson
7.7.1 Johnson?Johnson Corporate Summary
7.7.2 Johnson?Johnson Business Overview
7.7.3 Johnson?Johnson GP Vaccination Major Product Offerings
7.7.4 Johnson?Johnson GP Vaccination Sales and Revenue in Global (2017-2022)
7.7.5 Johnson?Johnson Key News
7.8 Heat Biologics
7.8.1 Heat Biologics Corporate Summary
7.8.2 Heat Biologics Business Overview
7.8.3 Heat Biologics GP Vaccination Major Product Offerings
7.8.4 Heat Biologics GP Vaccination Sales and Revenue in Global (2017-2022)
7.8.5 Heat Biologics Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi GP Vaccination Major Product Offerings
7.9.4 Sanofi GP Vaccination Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Key News
7.10 Takis Biotech
7.10.1 Takis Biotech Corporate Summary
7.10.2 Takis Biotech Business Overview
7.10.3 Takis Biotech GP Vaccination Major Product Offerings
7.10.4 Takis Biotech GP Vaccination Sales and Revenue in Global (2017-2022)
7.10.5 Takis Biotech Key News
7.11 Zydus Cadila
7.11.1 Zydus Cadila Corporate Summary
7.11.2 Zydus Cadila GP Vaccination Business Overview
7.11.3 Zydus Cadila GP Vaccination Major Product Offerings
7.11.4 Zydus Cadila GP Vaccination Sales and Revenue in Global (2017-2022)
7.11.5 Zydus Cadila Key News
7.12 Codagenix
7.12.1 Codagenix Corporate Summary
7.12.2 Codagenix GP Vaccination Business Overview
7.12.3 Codagenix GP Vaccination Major Product Offerings
7.12.4 Codagenix GP Vaccination Sales and Revenue in Global (2017-2022)
7.12.5 Codagenix Key News
7.13 GeoVax
7.13.1 GeoVax Corporate Summary
7.13.2 GeoVax GP Vaccination Business Overview
7.13.3 GeoVax GP Vaccination Major Product Offerings
7.13.4 GeoVax GP Vaccination Sales and Revenue in Global (2017-2022)
7.13.5 GeoVax Key News
7.14 Bravovax
7.14.1 Bravovax Corporate Summary
7.14.2 Bravovax Business Overview
7.14.3 Bravovax GP Vaccination Major Product Offerings
7.14.4 Bravovax GP Vaccination Sales and Revenue in Global (2017-2022)
7.14.5 Bravovax Key News
7.15 Altimmune
7.15.1 Altimmune Corporate Summary
7.15.2 Altimmune Business Overview
7.15.3 Altimmune GP Vaccination Major Product Offerings
7.15.4 Altimmune GP Vaccination Sales and Revenue in Global (2017-2022)
7.15.5 Altimmune Key News
7.16 Vaxart
7.16.1 Vaxart Corporate Summary
7.16.2 Vaxart Business Overview
7.16.3 Vaxart GP Vaccination Major Product Offerings
7.16.4 Vaxart GP Vaccination Sales and Revenue in Global (2017-2022)
7.16.5 Vaxart Key News
7.17 Clover Biopharmaceuticals
7.17.1 Clover Biopharmaceuticals Corporate Summary
7.17.2 Clover Biopharmaceuticals Business Overview
7.17.3 Clover Biopharmaceuticals GP Vaccination Major Product Offerings
7.17.4 Clover Biopharmaceuticals GP Vaccination Sales and Revenue in Global (2017-2022)
7.17.5 Clover Biopharmaceuticals Key News
7.18 ImmunoPrecise
7.18.1 ImmunoPrecise Corporate Summary
7.18.2 ImmunoPrecise Business Overview
7.18.3 ImmunoPrecise GP Vaccination Major Product Offerings
7.18.4 ImmunoPrecise GP Vaccination Sales and Revenue in Global (2017-2022)
7.18.5 ImmunoPrecise Key News
8 GLOBAL GP VACCINATION PRODUCTION CAPACITY, ANALYSIS
8.1 Global GP Vaccination Production Capacity, 2017-2028
8.2 GP Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global GP Vaccination Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GP VACCINATION SUPPLY CHAIN ANALYSIS
10.1 GP Vaccination Industry Value Chain
10.2 GP Vaccination Upstream Market
10.3 GP Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 GP Vaccination Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 GP Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GP Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GP VACCINATION OVERALL MARKET SIZE
2.1 Global GP Vaccination Market Size: 2021 VS 2028
2.2 Global GP Vaccination Revenue, Prospects & Forecasts: 2017-2028
2.3 Global GP Vaccination Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top GP Vaccination Players in Global Market
3.2 Top Global GP Vaccination Companies Ranked by Revenue
3.3 Global GP Vaccination Revenue by Companies
3.4 Global GP Vaccination Sales by Companies
3.5 Global GP Vaccination Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 GP Vaccination Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers GP Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 GP Vaccination Players in Global Market
3.8.1 List of Global Tier 1 GP Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 GP Vaccination Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global GP Vaccination Market Size Markets, 2021 & 2028
4.1.2 DNA
4.1.3 Non-replicating Viral Vector
4.1.4 Protein Subunit
4.1.5 RNA
4.1.6 Others
4.2 By Type - Global GP Vaccination Revenue & Forecasts
4.2.1 By Type - Global GP Vaccination Revenue, 2017-2022
4.2.2 By Type - Global GP Vaccination Revenue, 2023-2028
4.2.3 By Type - Global GP Vaccination Revenue Market Share, 2017-2028
4.3 By Type - Global GP Vaccination Sales & Forecasts
4.3.1 By Type - Global GP Vaccination Sales, 2017-2022
4.3.2 By Type - Global GP Vaccination Sales, 2023-2028
4.3.3 By Type - Global GP Vaccination Sales Market Share, 2017-2028
4.4 By Type - Global GP Vaccination Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global GP Vaccination Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global GP Vaccination Revenue & Forecasts
5.2.1 By Application - Global GP Vaccination Revenue, 2017-2022
5.2.2 By Application - Global GP Vaccination Revenue, 2023-2028
5.2.3 By Application - Global GP Vaccination Revenue Market Share, 2017-2028
5.3 By Application - Global GP Vaccination Sales & Forecasts
5.3.1 By Application - Global GP Vaccination Sales, 2017-2022
5.3.2 By Application - Global GP Vaccination Sales, 2023-2028
5.3.3 By Application - Global GP Vaccination Sales Market Share, 2017-2028
5.4 By Application - Global GP Vaccination Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global GP Vaccination Market Size, 2021 & 2028
6.2 By Region - Global GP Vaccination Revenue & Forecasts
6.2.1 By Region - Global GP Vaccination Revenue, 2017-2022
6.2.2 By Region - Global GP Vaccination Revenue, 2023-2028
6.2.3 By Region - Global GP Vaccination Revenue Market Share, 2017-2028
6.3 By Region - Global GP Vaccination Sales & Forecasts
6.3.1 By Region - Global GP Vaccination Sales, 2017-2022
6.3.2 By Region - Global GP Vaccination Sales, 2023-2028
6.3.3 By Region - Global GP Vaccination Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America GP Vaccination Revenue, 2017-2028
6.4.2 By Country - North America GP Vaccination Sales, 2017-2028
6.4.3 US GP Vaccination Market Size, 2017-2028
6.4.4 Canada GP Vaccination Market Size, 2017-2028
6.4.5 Mexico GP Vaccination Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe GP Vaccination Revenue, 2017-2028
6.5.2 By Country - Europe GP Vaccination Sales, 2017-2028
6.5.3 Germany GP Vaccination Market Size, 2017-2028
6.5.4 France GP Vaccination Market Size, 2017-2028
6.5.5 U.K. GP Vaccination Market Size, 2017-2028
6.5.6 Italy GP Vaccination Market Size, 2017-2028
6.5.7 Russia GP Vaccination Market Size, 2017-2028
6.5.8 Nordic Countries GP Vaccination Market Size, 2017-2028
6.5.9 Benelux GP Vaccination Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia GP Vaccination Revenue, 2017-2028
6.6.2 By Region - Asia GP Vaccination Sales, 2017-2028
6.6.3 China GP Vaccination Market Size, 2017-2028
6.6.4 Japan GP Vaccination Market Size, 2017-2028
6.6.5 South Korea GP Vaccination Market Size, 2017-2028
6.6.6 Southeast Asia GP Vaccination Market Size, 2017-2028
6.6.7 India GP Vaccination Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America GP Vaccination Revenue, 2017-2028
6.7.2 By Country - South America GP Vaccination Sales, 2017-2028
6.7.3 Brazil GP Vaccination Market Size, 2017-2028
6.7.4 Argentina GP Vaccination Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa GP Vaccination Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa GP Vaccination Sales, 2017-2028
6.8.3 Turkey GP Vaccination Market Size, 2017-2028
6.8.4 Israel GP Vaccination Market Size, 2017-2028
6.8.5 Saudi Arabia GP Vaccination Market Size, 2017-2028
6.8.6 UAE GP Vaccination Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Moderna
7.1.1 Moderna Corporate Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna GP Vaccination Major Product Offerings
7.1.4 Moderna GP Vaccination Sales and Revenue in Global (2017-2022)
7.1.5 Moderna Key News
7.2 CanSino Biologicals
7.2.1 CanSino Biologicals Corporate Summary
7.2.2 CanSino Biologicals Business Overview
7.2.3 CanSino Biologicals GP Vaccination Major Product Offerings
7.2.4 CanSino Biologicals GP Vaccination Sales and Revenue in Global (2017-2022)
7.2.5 CanSino Biologicals Key News
7.3 Inovio Pharmaceuticals
7.3.1 Inovio Pharmaceuticals Corporate Summary
7.3.2 Inovio Pharmaceuticals Business Overview
7.3.3 Inovio Pharmaceuticals GP Vaccination Major Product Offerings
7.3.4 Inovio Pharmaceuticals GP Vaccination Sales and Revenue in Global (2017-2022)
7.3.5 Inovio Pharmaceuticals Key News
7.4 Shenzhen Geno-Immune Medical Institute
7.4.1 Shenzhen Geno-Immune Medical Institute Corporate Summary
7.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
7.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Major Product Offerings
7.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales and Revenue in Global (2017-2022)
7.4.5 Shenzhen Geno-Immune Medical Institute Key News
7.5 GlaxoSmithKine
7.5.1 GlaxoSmithKine Corporate Summary
7.5.2 GlaxoSmithKine Business Overview
7.5.3 GlaxoSmithKine GP Vaccination Major Product Offerings
7.5.4 GlaxoSmithKine GP Vaccination Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKine Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer GP Vaccination Major Product Offerings
7.6.4 Pfizer GP Vaccination Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Johnson?Johnson
7.7.1 Johnson?Johnson Corporate Summary
7.7.2 Johnson?Johnson Business Overview
7.7.3 Johnson?Johnson GP Vaccination Major Product Offerings
7.7.4 Johnson?Johnson GP Vaccination Sales and Revenue in Global (2017-2022)
7.7.5 Johnson?Johnson Key News
7.8 Heat Biologics
7.8.1 Heat Biologics Corporate Summary
7.8.2 Heat Biologics Business Overview
7.8.3 Heat Biologics GP Vaccination Major Product Offerings
7.8.4 Heat Biologics GP Vaccination Sales and Revenue in Global (2017-2022)
7.8.5 Heat Biologics Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi GP Vaccination Major Product Offerings
7.9.4 Sanofi GP Vaccination Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Key News
7.10 Takis Biotech
7.10.1 Takis Biotech Corporate Summary
7.10.2 Takis Biotech Business Overview
7.10.3 Takis Biotech GP Vaccination Major Product Offerings
7.10.4 Takis Biotech GP Vaccination Sales and Revenue in Global (2017-2022)
7.10.5 Takis Biotech Key News
7.11 Zydus Cadila
7.11.1 Zydus Cadila Corporate Summary
7.11.2 Zydus Cadila GP Vaccination Business Overview
7.11.3 Zydus Cadila GP Vaccination Major Product Offerings
7.11.4 Zydus Cadila GP Vaccination Sales and Revenue in Global (2017-2022)
7.11.5 Zydus Cadila Key News
7.12 Codagenix
7.12.1 Codagenix Corporate Summary
7.12.2 Codagenix GP Vaccination Business Overview
7.12.3 Codagenix GP Vaccination Major Product Offerings
7.12.4 Codagenix GP Vaccination Sales and Revenue in Global (2017-2022)
7.12.5 Codagenix Key News
7.13 GeoVax
7.13.1 GeoVax Corporate Summary
7.13.2 GeoVax GP Vaccination Business Overview
7.13.3 GeoVax GP Vaccination Major Product Offerings
7.13.4 GeoVax GP Vaccination Sales and Revenue in Global (2017-2022)
7.13.5 GeoVax Key News
7.14 Bravovax
7.14.1 Bravovax Corporate Summary
7.14.2 Bravovax Business Overview
7.14.3 Bravovax GP Vaccination Major Product Offerings
7.14.4 Bravovax GP Vaccination Sales and Revenue in Global (2017-2022)
7.14.5 Bravovax Key News
7.15 Altimmune
7.15.1 Altimmune Corporate Summary
7.15.2 Altimmune Business Overview
7.15.3 Altimmune GP Vaccination Major Product Offerings
7.15.4 Altimmune GP Vaccination Sales and Revenue in Global (2017-2022)
7.15.5 Altimmune Key News
7.16 Vaxart
7.16.1 Vaxart Corporate Summary
7.16.2 Vaxart Business Overview
7.16.3 Vaxart GP Vaccination Major Product Offerings
7.16.4 Vaxart GP Vaccination Sales and Revenue in Global (2017-2022)
7.16.5 Vaxart Key News
7.17 Clover Biopharmaceuticals
7.17.1 Clover Biopharmaceuticals Corporate Summary
7.17.2 Clover Biopharmaceuticals Business Overview
7.17.3 Clover Biopharmaceuticals GP Vaccination Major Product Offerings
7.17.4 Clover Biopharmaceuticals GP Vaccination Sales and Revenue in Global (2017-2022)
7.17.5 Clover Biopharmaceuticals Key News
7.18 ImmunoPrecise
7.18.1 ImmunoPrecise Corporate Summary
7.18.2 ImmunoPrecise Business Overview
7.18.3 ImmunoPrecise GP Vaccination Major Product Offerings
7.18.4 ImmunoPrecise GP Vaccination Sales and Revenue in Global (2017-2022)
7.18.5 ImmunoPrecise Key News
8 GLOBAL GP VACCINATION PRODUCTION CAPACITY, ANALYSIS
8.1 Global GP Vaccination Production Capacity, 2017-2028
8.2 GP Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global GP Vaccination Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GP VACCINATION SUPPLY CHAIN ANALYSIS
10.1 GP Vaccination Industry Value Chain
10.2 GP Vaccination Upstream Market
10.3 GP Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 GP Vaccination Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of GP Vaccination in Global Market
Table 2. Top GP Vaccination Players in Global Market, Ranking by Revenue (2021)
Table 3. Global GP Vaccination Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global GP Vaccination Revenue Share by Companies, 2017-2022
Table 5. Global GP Vaccination Sales by Companies, (K Units), 2017-2022
Table 6. Global GP Vaccination Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers GP Vaccination Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers GP Vaccination Product Type
Table 9. List of Global Tier 1 GP Vaccination Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GP Vaccination Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global GP Vaccination Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global GP Vaccination Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global GP Vaccination Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global GP Vaccination Sales (K Units), 2017-2022
Table 15. By Type - Global GP Vaccination Sales (K Units), 2023-2028
Table 16. By Application – Global GP Vaccination Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global GP Vaccination Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global GP Vaccination Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global GP Vaccination Sales (K Units), 2017-2022
Table 20. By Application - Global GP Vaccination Sales (K Units), 2023-2028
Table 21. By Region – Global GP Vaccination Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global GP Vaccination Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global GP Vaccination Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global GP Vaccination Sales (K Units), 2017-2022
Table 25. By Region - Global GP Vaccination Sales (K Units), 2023-2028
Table 26. By Country - North America GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America GP Vaccination Sales, (K Units), 2017-2022
Table 29. By Country - North America GP Vaccination Sales, (K Units), 2023-2028
Table 30. By Country - Europe GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe GP Vaccination Sales, (K Units), 2017-2022
Table 33. By Country - Europe GP Vaccination Sales, (K Units), 2023-2028
Table 34. By Region - Asia GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia GP Vaccination Sales, (K Units), 2017-2022
Table 37. By Region - Asia GP Vaccination Sales, (K Units), 2023-2028
Table 38. By Country - South America GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America GP Vaccination Sales, (K Units), 2017-2022
Table 41. By Country - South America GP Vaccination Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa GP Vaccination Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa GP Vaccination Sales, (K Units), 2023-2028
Table 46. Moderna Corporate Summary
Table 47. Moderna GP Vaccination Product Offerings
Table 48. Moderna GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CanSino Biologicals Corporate Summary
Table 50. CanSino Biologicals GP Vaccination Product Offerings
Table 51. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Inovio Pharmaceuticals Corporate Summary
Table 53. Inovio Pharmaceuticals GP Vaccination Product Offerings
Table 54. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Shenzhen Geno-Immune Medical Institute Corporate Summary
Table 56. Shenzhen Geno-Immune Medical Institute GP Vaccination Product Offerings
Table 57. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GlaxoSmithKine Corporate Summary
Table 59. GlaxoSmithKine GP Vaccination Product Offerings
Table 60. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer GP Vaccination Product Offerings
Table 63. Pfizer GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Johnson?Johnson Corporate Summary
Table 65. Johnson?Johnson GP Vaccination Product Offerings
Table 66. Johnson?Johnson GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Heat Biologics Corporate Summary
Table 68. Heat Biologics GP Vaccination Product Offerings
Table 69. Heat Biologics GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Sanofi Corporate Summary
Table 71. Sanofi GP Vaccination Product Offerings
Table 72. Sanofi GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Takis Biotech Corporate Summary
Table 74. Takis Biotech GP Vaccination Product Offerings
Table 75. Takis Biotech GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Zydus Cadila Corporate Summary
Table 77. Zydus Cadila GP Vaccination Product Offerings
Table 78. Zydus Cadila GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Codagenix Corporate Summary
Table 80. Codagenix GP Vaccination Product Offerings
Table 81. Codagenix GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. GeoVax Corporate Summary
Table 83. GeoVax GP Vaccination Product Offerings
Table 84. GeoVax GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Bravovax Corporate Summary
Table 86. Bravovax GP Vaccination Product Offerings
Table 87. Bravovax GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Altimmune Corporate Summary
Table 89. Altimmune GP Vaccination Product Offerings
Table 90. Altimmune GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Vaxart Corporate Summary
Table 92. Vaxart GP Vaccination Product Offerings
Table 93. Vaxart GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Clover Biopharmaceuticals Corporate Summary
Table 95. Clover Biopharmaceuticals GP Vaccination Product Offerings
Table 96. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. ImmunoPrecise Corporate Summary
Table 98. ImmunoPrecise GP Vaccination Product Offerings
Table 99. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. GP Vaccination Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 101. Global GP Vaccination Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global GP Vaccination Production by Region, 2017-2022 (K Units)
Table 103. Global GP Vaccination Production by Region, 2023-2028 (K Units)
Table 104. GP Vaccination Market Opportunities & Trends in Global Market
Table 105. GP Vaccination Market Drivers in Global Market
Table 106. GP Vaccination Market Restraints in Global Market
Table 107. GP Vaccination Raw Materials
Table 108. GP Vaccination Raw Materials Suppliers in Global Market
Table 109. Typical GP Vaccination Downstream
Table 110. GP Vaccination Downstream Clients in Global Market
Table 111. GP Vaccination Distributors and Sales Agents in Global Market
Table 1. Key Players of GP Vaccination in Global Market
Table 2. Top GP Vaccination Players in Global Market, Ranking by Revenue (2021)
Table 3. Global GP Vaccination Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global GP Vaccination Revenue Share by Companies, 2017-2022
Table 5. Global GP Vaccination Sales by Companies, (K Units), 2017-2022
Table 6. Global GP Vaccination Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers GP Vaccination Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers GP Vaccination Product Type
Table 9. List of Global Tier 1 GP Vaccination Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GP Vaccination Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global GP Vaccination Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global GP Vaccination Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global GP Vaccination Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global GP Vaccination Sales (K Units), 2017-2022
Table 15. By Type - Global GP Vaccination Sales (K Units), 2023-2028
Table 16. By Application – Global GP Vaccination Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global GP Vaccination Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global GP Vaccination Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global GP Vaccination Sales (K Units), 2017-2022
Table 20. By Application - Global GP Vaccination Sales (K Units), 2023-2028
Table 21. By Region – Global GP Vaccination Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global GP Vaccination Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global GP Vaccination Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global GP Vaccination Sales (K Units), 2017-2022
Table 25. By Region - Global GP Vaccination Sales (K Units), 2023-2028
Table 26. By Country - North America GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America GP Vaccination Sales, (K Units), 2017-2022
Table 29. By Country - North America GP Vaccination Sales, (K Units), 2023-2028
Table 30. By Country - Europe GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe GP Vaccination Sales, (K Units), 2017-2022
Table 33. By Country - Europe GP Vaccination Sales, (K Units), 2023-2028
Table 34. By Region - Asia GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia GP Vaccination Sales, (K Units), 2017-2022
Table 37. By Region - Asia GP Vaccination Sales, (K Units), 2023-2028
Table 38. By Country - South America GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America GP Vaccination Sales, (K Units), 2017-2022
Table 41. By Country - South America GP Vaccination Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa GP Vaccination Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa GP Vaccination Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa GP Vaccination Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa GP Vaccination Sales, (K Units), 2023-2028
Table 46. Moderna Corporate Summary
Table 47. Moderna GP Vaccination Product Offerings
Table 48. Moderna GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CanSino Biologicals Corporate Summary
Table 50. CanSino Biologicals GP Vaccination Product Offerings
Table 51. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Inovio Pharmaceuticals Corporate Summary
Table 53. Inovio Pharmaceuticals GP Vaccination Product Offerings
Table 54. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Shenzhen Geno-Immune Medical Institute Corporate Summary
Table 56. Shenzhen Geno-Immune Medical Institute GP Vaccination Product Offerings
Table 57. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GlaxoSmithKine Corporate Summary
Table 59. GlaxoSmithKine GP Vaccination Product Offerings
Table 60. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer GP Vaccination Product Offerings
Table 63. Pfizer GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Johnson?Johnson Corporate Summary
Table 65. Johnson?Johnson GP Vaccination Product Offerings
Table 66. Johnson?Johnson GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Heat Biologics Corporate Summary
Table 68. Heat Biologics GP Vaccination Product Offerings
Table 69. Heat Biologics GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Sanofi Corporate Summary
Table 71. Sanofi GP Vaccination Product Offerings
Table 72. Sanofi GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Takis Biotech Corporate Summary
Table 74. Takis Biotech GP Vaccination Product Offerings
Table 75. Takis Biotech GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Zydus Cadila Corporate Summary
Table 77. Zydus Cadila GP Vaccination Product Offerings
Table 78. Zydus Cadila GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Codagenix Corporate Summary
Table 80. Codagenix GP Vaccination Product Offerings
Table 81. Codagenix GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. GeoVax Corporate Summary
Table 83. GeoVax GP Vaccination Product Offerings
Table 84. GeoVax GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Bravovax Corporate Summary
Table 86. Bravovax GP Vaccination Product Offerings
Table 87. Bravovax GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Altimmune Corporate Summary
Table 89. Altimmune GP Vaccination Product Offerings
Table 90. Altimmune GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Vaxart Corporate Summary
Table 92. Vaxart GP Vaccination Product Offerings
Table 93. Vaxart GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Clover Biopharmaceuticals Corporate Summary
Table 95. Clover Biopharmaceuticals GP Vaccination Product Offerings
Table 96. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. ImmunoPrecise Corporate Summary
Table 98. ImmunoPrecise GP Vaccination Product Offerings
Table 99. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. GP Vaccination Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 101. Global GP Vaccination Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global GP Vaccination Production by Region, 2017-2022 (K Units)
Table 103. Global GP Vaccination Production by Region, 2023-2028 (K Units)
Table 104. GP Vaccination Market Opportunities & Trends in Global Market
Table 105. GP Vaccination Market Drivers in Global Market
Table 106. GP Vaccination Market Restraints in Global Market
Table 107. GP Vaccination Raw Materials
Table 108. GP Vaccination Raw Materials Suppliers in Global Market
Table 109. Typical GP Vaccination Downstream
Table 110. GP Vaccination Downstream Clients in Global Market
Table 111. GP Vaccination Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. GP Vaccination Segment by Type
Figure 2. GP Vaccination Segment by Application
Figure 3. Global GP Vaccination Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global GP Vaccination Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global GP Vaccination Revenue, 2017-2028 (US$, Mn)
Figure 7. GP Vaccination Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by GP Vaccination Revenue in 2021
Figure 9. By Type - Global GP Vaccination Sales Market Share, 2017-2028
Figure 10. By Type - Global GP Vaccination Revenue Market Share, 2017-2028
Figure 11. By Type - Global GP Vaccination Price (US$/Unit), 2017-2028
Figure 12. By Application - Global GP Vaccination Sales Market Share, 2017-2028
Figure 13. By Application - Global GP Vaccination Revenue Market Share, 2017-2028
Figure 14. By Application - Global GP Vaccination Price (US$/Unit), 2017-2028
Figure 15. By Region - Global GP Vaccination Sales Market Share, 2017-2028
Figure 16. By Region - Global GP Vaccination Revenue Market Share, 2017-2028
Figure 17. By Country - North America GP Vaccination Revenue Market Share, 2017-2028
Figure 18. By Country - North America GP Vaccination Sales Market Share, 2017-2028
Figure 19. US GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 20. Canada GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe GP Vaccination Revenue Market Share, 2017-2028
Figure 23. By Country - Europe GP Vaccination Sales Market Share, 2017-2028
Figure 24. Germany GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 25. France GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 27. Italy GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 28. Russia GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia GP Vaccination Revenue Market Share, 2017-2028
Figure 32. By Region - Asia GP Vaccination Sales Market Share, 2017-2028
Figure 33. China GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 34. Japan GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 37. India GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America GP Vaccination Revenue Market Share, 2017-2028
Figure 39. By Country - South America GP Vaccination Sales Market Share, 2017-2028
Figure 40. Brazil GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa GP Vaccination Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa GP Vaccination Sales Market Share, 2017-2028
Figure 44. Turkey GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 45. Israel GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 47. UAE GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 48. Global GP Vaccination Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production GP Vaccination by Region, 2021 VS 2028
Figure 50. GP Vaccination Industry Value Chain
Figure 51. Marketing Channels
Figure 1. GP Vaccination Segment by Type
Figure 2. GP Vaccination Segment by Application
Figure 3. Global GP Vaccination Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global GP Vaccination Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global GP Vaccination Revenue, 2017-2028 (US$, Mn)
Figure 7. GP Vaccination Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by GP Vaccination Revenue in 2021
Figure 9. By Type - Global GP Vaccination Sales Market Share, 2017-2028
Figure 10. By Type - Global GP Vaccination Revenue Market Share, 2017-2028
Figure 11. By Type - Global GP Vaccination Price (US$/Unit), 2017-2028
Figure 12. By Application - Global GP Vaccination Sales Market Share, 2017-2028
Figure 13. By Application - Global GP Vaccination Revenue Market Share, 2017-2028
Figure 14. By Application - Global GP Vaccination Price (US$/Unit), 2017-2028
Figure 15. By Region - Global GP Vaccination Sales Market Share, 2017-2028
Figure 16. By Region - Global GP Vaccination Revenue Market Share, 2017-2028
Figure 17. By Country - North America GP Vaccination Revenue Market Share, 2017-2028
Figure 18. By Country - North America GP Vaccination Sales Market Share, 2017-2028
Figure 19. US GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 20. Canada GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe GP Vaccination Revenue Market Share, 2017-2028
Figure 23. By Country - Europe GP Vaccination Sales Market Share, 2017-2028
Figure 24. Germany GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 25. France GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 27. Italy GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 28. Russia GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia GP Vaccination Revenue Market Share, 2017-2028
Figure 32. By Region - Asia GP Vaccination Sales Market Share, 2017-2028
Figure 33. China GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 34. Japan GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 37. India GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America GP Vaccination Revenue Market Share, 2017-2028
Figure 39. By Country - South America GP Vaccination Sales Market Share, 2017-2028
Figure 40. Brazil GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa GP Vaccination Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa GP Vaccination Sales Market Share, 2017-2028
Figure 44. Turkey GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 45. Israel GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 47. UAE GP Vaccination Revenue, (US$, Mn), 2017-2028
Figure 48. Global GP Vaccination Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production GP Vaccination by Region, 2021 VS 2028
Figure 50. GP Vaccination Industry Value Chain
Figure 51. Marketing Channels
